<DOC>
	<DOC>NCT00777868</DOC>
	<brief_summary>The purpose of this study is to assess the safety and effectiveness of two concentrations of IDP-108 in treating patients with onychomycosis</brief_summary>
	<brief_title>A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis</brief_title>
	<detailed_description />
	<mesh_term>Onychomycosis</mesh_term>
	<criteria>Presence of onychomycosis of the target toenail A positive fungal culture from the target toenail Any disease or condition that might cause nail abnormalities or may interfere with clinical evaluations Presence of tinea pedis (athletes foot) Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>